Skip to main content
Mobile Main navigation
Expand
Our Company
About Alnylam
Leadership
Diversity, Equity & Inclusion
Patient Access Philosophy
Corporate Responsibility
Transparency
Grants & Giving
Investigator Initiated Studies (IIS)
Expand
Our Science
The Science of RNAi
Delivery Platforms
Therapeutic Areas
Pipeline
Clinical Trials
Scientific Advisory Board
Intellectual Property
Capella (Scientific Presentations)
Expand
Our Products
Product Listing
Expand
Our News
Newsroom
Press Releases
Capella (Scientific Presentations)
Media Kit
Expand
Investors
For Investors
Stock Information
Investors Toolkit
Events & Presentations
Financial Information
SEC Filings
Corporate Governance
Analyst Coverage
Fundamentals
Ownership Profile
Annual Meetings
Press Releases
Capella (Scientific Presentations)
FAQs
Expand
Medical Professionals
For Medical Professionals
Genetic Testing & Counseling
Early Access Program
Medical Publication Support
Investigator Initiated Studies (IIS)
Expand
Patients
For Patients
Amyloidosis
Acute Hepatic Porphyria
Primary Hyperoxaluria
Patient Services
Genetic Testing and Counseling
Patient Advocacy
Expand
Job Seekers
Careers
Working at Alnylam
Who We Are
Career Opportunities
Search Jobs
Diversity, Equity & Inclusion
Expand
Quick Links
Clinical Trials
Corporate Responsibility
Diversity, Equity & Inclusion
Press Releases
Capella (Scientific Presentations)
Medical Resources (RNAi Science)
Contact Us
Follow Us:
youtube
facebook
X
linkedin
instagram
Our Company
»
About Alnylam
Leadership
Diversity, Equity & Inclusion
Patient Access Philosophy
Corporate Responsibility
Transparency
Grants & Giving
Investigator Initiated Studies (IIS)
Our Science
»
The Science of RNAi
Delivery Platforms
Therapeutic Areas
Pipeline
Clinical Trials
Scientific Advisory Board
Intellectual Property
Capella (Scientific Presentations)
Our Products
»
Product Listing
Our News
»
Newsroom
Press Releases
Capella (Scientific Presentations)
Media Kit
Investors
»
For Investors
Stock Information
Investors Toolkit
Events & Presentations
Financial Information
SEC Filings
Corporate Governance
Analyst Coverage
Fundamentals
Ownership Profile
Annual Meetings
Press Releases
Capella (Scientific Presentations)
FAQs
Medical Professionals
»
For Medical Professionals
Genetic Testing & Counseling
Early Access Program
Medical Publication Support
Investigator Initiated Studies (IIS)
Patients
»
For Patients
Amyloidosis
Acute Hepatic Porphyria
Primary Hyperoxaluria
Patient Services
Genetic Testing and Counseling
Patient Advocacy
Job Seekers
»
Careers
Working at Alnylam
Who We Are
Career Opportunities
Search Jobs
Diversity, Equity & Inclusion
Quick Links
»
Clinical Trials
Corporate Responsibility
Diversity, Equity & Inclusion
Press Releases
Capella (Scientific Presentations)
Medical Resources (RNAi Science)
Contact Us
Follow Us:
youtube
facebook
X
linkedin
instagram
search
Sort by
Sort By:
Order
Sort by: Most Recent
Sort by: Oldest
Search
language
Global
English
Austria
Deutsch
Belgium
Nederlands
Français
Brazil
Português
Canada
Français
English
Denmark
Dansk
France
Français
Germany
Deutsch
Ireland
English
Italy
Italiano
Japan
日本語
Luxembourg
Français
Deutsch
Netherlands
Nederlands
Portugal
Português
Spain
Español
Sweden
Svenska
Switzerland
Français
Deutsch
Italiano
Taiwan
繁體中文
United Kingdom
English
Investors
For Investors
Stock Information
Investors Toolkit
Events & Presentations
Financial Information
SEC Filings
Corporate Governance
Analyst Coverage
Fundamentals
Ownership Profile
Annual Meetings
Press Releases
Capella (Scientific Presentations)
FAQs
Medical Professionals
For Medical Professionals
Genetic Testing & Counseling
Early Access Program
Medical Publication Support
Investigator Initiated Studies (IIS)
Patients
For Patients
Amyloidosis
Acute Hepatic Porphyria
Primary Hyperoxaluria
Patient Services
Genetic Testing and Counseling
Patient Advocacy
Job Seekers
Careers
Working at Alnylam
Who We Are
Career Opportunities
Search Jobs
Diversity, Equity & Inclusion
Quick Links
Clinical Trials
Corporate Responsibility
Diversity, Equity & Inclusion
Press Releases
Capella (Scientific Presentations)
Medical Resources (RNAi Science)
Contact Us
Follow Us
Youtube
Facebook
X
LinkedIn
Instagram
Sign Up
language
Our Company
About Alnylam
Leadership
Diversity, Equity & Inclusion
Patient Access Philosophy
Corporate Responsibility
Transparency
Grants & Giving
Investigator Initiated Studies (IIS)
Our Science
The Science of RNAi
Delivery Platforms
Therapeutic Areas
Pipeline
Clinical Trials
Scientific Advisory Board
Intellectual Property
Capella (Scientific Presentations)
Our Products
Product Listing
Our News
Newsroom
Press Releases
Capella (Scientific Presentations)
Media Kit
search
Sort by
Sort By:
Order
Sort by: Most Recent
Sort by: Oldest
Search
Global
English
Austria
Deutsch
Japan
日本語
Belgium
Nederlands
Français
Luxembourg
Français
Deutsch
Brazil
Português
Netherlands
Nederlands
Canada
Français
English
Portugal
Português
Spain
Español
Denmark
Dansk
Sweden
Svenska
France
Français
Switzerland
Français
Deutsch
Italiano
Germany
Deutsch
Taiwan
繁體中文
Ireland
English
United Kingdom
English
Italy
Italiano
Proxy Material Id
8701
Proxy Material Title
2011 10-K
Proxy Material Date
Tue, 12/27/2011 - 00:00